Cognitive Training for Post-Transplant Cognitive Impairment
(cTAG Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a brain-training program called Lumosity can improve memory and thinking skills in individuals who have undergone a blood stem cell transplant. It also examines participants' interest in learning about their genetic risk for cognitive issues post-transplant. Two groups participate: one begins the Lumosity program immediately, while the other starts after three months. Eligible participants must have had a stem cell transplant at least three months prior, be in outpatient care, and have internet access. Participants should not have major neurological or psychiatric issues or have recently participated in a similar brain-training program. As an unphased trial, this study offers a unique opportunity to contribute to understanding cognitive recovery after stem cell transplants.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Lumosity program is safe for improving neurocognitive function in HCT survivors?
Research has shown that Lumosity, a brain training program, is generally safe for use. In past studies, participants engaged in various games and exercises on Lumosity to train their brains. These studies have not identified any major negative side effects from using the program.
For instance, one study tested Lumosity and found it helped maintain thinking skills without harming participants. Another study suggested that playing brain games like those in Lumosity might help slow mental decline in some areas, again without causing major problems.
Overall, the evidence indicates that Lumosity is well-tolerated by users. Participants in these studies did not report any serious issues from using the program. This suggests that Lumosity is a safe choice for those looking to improve or maintain their mental abilities.12345Why are researchers excited about this trial?
Researchers are excited about using Lumosity for post-transplant cognitive impairment because it offers a non-pharmacological approach to improving cognitive function. Unlike standard treatments that may focus on medication to manage symptoms, Lumosity is a brain-training program that uses engaging games and exercises to potentially enhance memory, attention, and problem-solving skills. This method is appealing because it is user-friendly, accessible from home, and can be tailored to individual cognitive needs, providing a personalized experience that traditional treatments may lack.
What evidence suggests that the Lumosity program is effective for improving neurocognitive function in HCT survivors?
Research shows that brain training programs like Lumosity can enhance brain function. Studies have found that these computer-based exercises can slow mental decline, keeping the brain sharp. In similar situations, such as surgery, brain training has reduced issues like confusion and memory loss shortly after the operation. In this trial, one group of participants will begin the Lumosity program at enrollment, while another group will start three months later. Although specific data for hematopoietic cell transplantation (HCT) survivors is limited, these findings suggest that Lumosity might also improve brain function in HCT survivors.26789
Who Is on the Research Team?
Noha Sharafeldin, MD, MSc, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults over 21 who had a bone marrow transplant at UAB, are 3-6 months post-transplant, and can use an internet-connected computer. It's not for those with neurological or major psychiatric disorders, significant sensory/motor issues, color blindness, or recent neuropsychological intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in daily cognitive training using the Lumosity program for 12 weeks
Follow-up
Participants are monitored for changes in cognitive function and attitudes towards genetic information
What Are the Treatments Tested in This Trial?
Interventions
- Lumosity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor